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Background
The aim of this study is to evaluate soluble tumor
necrosis factor-related apoptosis inducing ligand (sApo
2L, sTRAIL) levels in ascites fluid to predict its clinical
usage in detecting malignant ascites and soluble CD200
(sCD200, sOX-2) levels to predict its clinical usage in
blood detecting breast cancer.
Methods
Ascites and sera samples from patients without known
malignancy at the admission were collected. There were
14 stage-4 breast cancer (BC), 17 stage-4 ovarian cancer
(OC) and 19 stage-4 endometrial cancer (EC) diagnosed
later on. Control groups consisted of benign peritoneal
fluids (n=53) and sera samples (n=25) from healthy
subjects.
Concentrations of sCD200 in the serum samples were
quantified using ELISA kit. CEA (Beckman Coulter Sys-
tem. Catalog Number:33200), CA-19.9(Beckman Coulter
System. Catalog Number:387687), CA-125 (Beckman
Coulter System. Catalog Number:386357) and CA15.3
(Beckman Coulter System. Catalog Number: 387620).
Levels were enumerated by fluoroenzyme immunoassay.
Concentrations of sTRAIL in the serum samples were
quantified using ELISA kits (Diaclone, France).
Results
The significant low level of sApo 2L was observed in
peritoneal fluids from OC and EC patients than benign
peritoneal fluids from control patients. Besides, positive
correlation was observed between sApo 2L and aspartate
aminotransferase (AST) in benign peritoneal fluid and
sOX-2 and creatinine and sOX-2 and platelet in OC
patients and sOX-2 and carcinoembrionic antigen
(CEA) in EC patients and sOX-2 and blood urea nitro-
gen (BUN) in healthy subjects.
Conclusions
Our data indicate that low level of sApo 2L is a good
biochemical marker detecting malignant ascites. Further
decline in the level of sApo 2L was seen in EC than OC.
Since higher level of sApo 2L was seen in higher level of
AST, liver might involved its metabolism. Positive corre-
lation detected between sOX-2 and creatinine, platelet,
CEA, BUN needs to be elucidated.
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